BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Science Corporation Acquires Pixium’s PRIMA Retinal Implant, Extending and Diversifying Its Commitment to Vision Restoration Through Brain-Computer Interface Technology

  Science Corporation has acquired the IP and related assets for the PRIMA retinal implant.

  April 25, 2024

   · 

  3 min read
• Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

  Santhera Pharmaceuticals announces the Company’s preliminary unaudited financial results for the year ended December 31, 2023, reports on business progress achieved in 2023 and extending into 2024, and provides updates on its strategic and financing initiatives.

  April 25, 2024

   · 

  29 min read
• ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date

  ONWARD Medical N.V., a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury, announces its Full Year 2023 Financial and Operating Results.

  April 25, 2024

   · 

  12 min read
• Business

  Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update

  Verona Pharma plc announces that it will report its financial results for the first quarter ended March 31, 2024 on Thursday, May 9, 2024 and host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m. BST to discuss these financial results and provide a corporate update.

  April 25, 2024

   · 

  2 min read
• PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono

  PRISM BioLab, Co. Ltd. announced that it has entered into a target-exclusive research and licensing agreement with ONO PHARMACEUTICAL CO., LTD.

  April 25, 2024

   · 

  3 min read
• Business

  Indivior Announces Q1 2024 Financial Results

  Indivior PLC announced its financial results for the period ending March 31, 2024.

  April 25, 2024

   · 

  1 min read
• Business

  Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio

  Swedish Orphan Biovitrum AB announced its report for the first quarter 2024.

  April 25, 2024

   · 

  3 min read
• Business

  AlzeCure Publishes its Interim Report for January - March 2024

  AlzeCure Pharma AlzeCure Pharma AB announced that its interim report for the period January - March 2024 is now available on the company’s website.

  April 25, 2024

   · 

  4 min read
• Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

  Hyundai Bioscience announced on April 25th that its clinical development plan of oral “Niclosamide Metabolic Anticancer Drug” targeting cancer patients with intractable cancer caused by p53 gene mutations.

  April 25, 2024

   · 

  3 min read
• Business

  West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend

  West Pharmaceutical Services, Inc. announced its financial results for the first-quarter 2024 and updated full-year 2024 financial guidance.

  April 25, 2024

   · 

  13 min read